Gumisad, Rhisalyn C.

HRN: 21-66-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2022
CEFUROXIME 500MG (TAB)
07/11/2022
07/16/2022
ORAL
500mg
BID
Status Post CS

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines